Glenn Lesser is an Oncology physician affiliated with Wake Forest University School of Medicine. OpenAlex indexes 466 publications with 10,252 citations (h-index 48); ClinicalTrials.gov lists 16 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Medical Center Blvd
Winston Salem, NC 271570001
Telephone
336-716-2255Registry record last updated 13 May 2008.
Clinical trials
- Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
Sponsor: Wake Forest University Health Sciences
- Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
Sponsor: Wake Forest University Health Sciences
- Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Servier BioInnovationProgram year20251 payment$18,750openpaymentsdata.cms.gov ↗
- JAZZ PHARMACEUTICALS INC.Program year20251 payment
- Novocure Inc.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
37.2%Other antiepileptics14.9%Levetiracetam100%Part D<11 patientsSSRI9%Sertraline Hcl100%Part D<11 patients+ 2 more classes in this area
Sensory organs
25.5%Corticosteroid25.5%Dexamethasone73%Hydrocortisone27%Part D<11 patientsMetabolism & gastrointestinal
23.9%Serotonin-3 Receptor Antagonist12.8%Ondansetron Hcl100%Part D≥13 patientsProton pump inhibitor11.2%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1998–2025 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas
New England Journal of Medicine
2023 - Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
International Journal of Radiation Oncology*Biology*Physics
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Dalane Kitzman, MD
Wake Forest University School of Medicine
Michael Rocco, MD
Wake Forest University School of Medicine
Lindsay Strowd, MD
Wake Forest University School of Medicine
Stephen Peters, MD
Wake Forest University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”